Filing Flows › Abbott Laboratories (ABT) › How it makes money
How Abbott Laboratories (ABT) makes money
Abbott Laboratories (ABT) made $13.0B of revenue in the third quarter 2026 (Q3 2026), +14% from a year earlier. Of every dollar of revenue, 10¢ was left as operating profit, 7¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $13.0B | 100.0% |
| Operating profit | $1.4B | 10.4% |
| Income tax | $311M | 2.4% |
| Net earnings | $920M | 7.1% |
| Operating cash flow | $1.7B | 13.3% |
| Free cash flow | $1.2B | 9.4% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $13.0B | +14% |
| Q2 2026 | $12.6B | +13% |
| Q1 2026 | $11.2B | +8% |
| Q4 2025 | $11.5B | +4% |
| Q3 2025 | $11.4B | +7% |
| Q2 2025 | $11.1B | +7% |
| Q1 2025 | $10.4B | +4% |
From Abbott Laboratories' 10-Q filed Nov 4, 2026 (on EDGAR).
Questions
How does Abbott Laboratories make money?
Abbott Laboratories (ABT) made $13.0B of revenue in the third quarter 2026 (Q3 2026), +14% from a year earlier. Of every dollar of revenue, 10¢ was left as operating profit, 7¢ was left as net earnings.
What is Abbott Laboratories' profit margin?
Net earnings were $920M, 7.1% of revenue, in the third quarter 2026; the operating margin was 10.4%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.